InvestorsHub Logo
Followers 23
Posts 2525
Boards Moderated 0
Alias Born 10/26/2003

Re: DewDiligence post# 355

Thursday, 03/01/2018 1:20:36 PM

Thursday, March 01, 2018 1:20:36 PM

Post# of 7253

That's unclear, and it's the reason I'm still not sure whether I like the deal.

I think this is a no brainer deal (although terms could always have been better). IMO, RVNC can now reap the benefits of the expanded market that could explode when there's a cheaper generic/biosimilar of BOTOX. For those who want best in class they'll pay up for RT002 but RVNC will now also enjoy the benefits of the second class biosimilar.

What would you have liked RVNC to have done? Nothing or create its own BOTOX biosimilar without a partner?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News